FASLG and autoimmune polyendocrinopathy: Moderate agreement was observed in the triple aPL+ APS patients between the Genesia® using TM and the CAT using rhAPC or Protac® but not in double or single aPL positive APS patients, which showed fair and poor agreement between either method (Figure S2, Table 2).